CME Options – CME-certified programs developed independently by CCO's educational partners



Trends and Controversy in NRTI-Based ART – a moderated discussion – Session 2 (coming soon)


Program Director: Mark A. Wainberg, PhD

Faculty: Eric S. Daar, MD, Benjamin Young, MD, PhD


CME CREDIT INFORMATION

Release Date: 01/10/07

Expiration Date: 01/09/08


Physicians: maximum of 1.25 AMA PRA Category 1 Credit(s)™

Status: Please log in to view status


Learning Objectives

Upon completion of this activity, participants should be able to:

  • Discuss the changing role of NRTIs, including fixed-dose combinations, in current and emerging anti-HIV treatment strategies
  • Explain the similarities and differences in safety of currently available NRTIs in the context of treatment selection and comorbidities in the HIV-infected patient
  • Describe current NRTI-based dosing strategies for initial as well as switch therapies
  • Discuss the potential impact of NRTI resistance mutations on optimal, initial, and subsequent antiretroviral therapeutic regimens (sequencing)
  • Identify salient issues related to the implementation of currently available NRTIs in antiretroviral regimens in resource-limited settings
  • Discuss certain drug resistance mutations with regard to HIV-1 fitness and potential impact on anti-HIV/AIDS therapy
  • Review the current and future role of thymidine analogs in first-line therapy

Produced by Continuing Edge,
a division of Global Edge, Inc.
© 2006 Global Edge, Inc. New York, NY
All rights reserved

Scientific Editor – Michael Pellegrino, PhD

Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.

Jointly sponsored by Postgraduate Institute for Medicine and Continuing Edge, a division of Global Edge, Inc.

Educational grant provided by:

Educational grants support only the CME-certified components of this program.

Coordinated by Continuing Edge, a division of Global Edge, Inc.